OXGENE
Dead / Abandoned — Abandoned — after ex parte appeal (as of 11 Jul 2023)
What this means for you
This application is over — abandoned 11 Jul 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79294279
- Mark type
- Stylized text
- Filed
- 19 Nov 2019
- Abandoned
- 11 Jul 2023
- Attorney of record
- THOMAS J MOORE
Goods and services
- Class 001 — Chemicals: Chemicals and biological preparations for use in science and industry; nucleic acids for laboratory use and not for medical and veterinary purposes; nucleic acids, namely, nucleic recombinant acids and synthetic deoxyribonucleic acids for laboratory use and not for medical and veterinary purposes; chemical and biological reagents for non-medical purposes, namely, reagents for use in scientific apparatus for chemical or biological analysis; human and animal cells and parts, namely, cells for non-medical purposes in the nature of scientific and research use; cultures of microorganisms for non-medical and non-veterinary purposes; human and animal cells and parts, namely, cells for scientific and research purposes; cultures of microorganisms for scientific and research purposes, other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Chemical and biological reagents for medical and veterinary diagnostic purposes; diagnostic reagents and diagnostic test reagents for medical and veterinary use; human and animal cells and parts thereof, namely, stem cells for medical and veterinary purposes; cultures of microorganisms for medical and veterinary purposes
- Class 042 — Scientific and technological services: Custom design services, namely, the creation and alteration of chemical and biological reagents; Scientific design services, namely, the creation and alteration of nucleic acids in the nature of nucleic recombinant acids and synthetic deoxyribonucleic acids; scientific design services, namely, development in the nature of the creation and alteration of recombinant viruses; scientific design services, namely, development in the nature of the creation and alteration of antibodies; scientific design services, namely, development in the nature of creation and alteration of cell lines and elementary cells
Owner
Prosecution history
- 19 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Aug 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Jul 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Jul 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 21 Jul 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 11 Jul 2023 — ABANDONMENT - AFTER EX PARTE APPEAL
- 11 Jul 2023 — EXPARTE APPEAL TERMINATED
- 23 May 2023 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 11 Jan 2023 — EX PARTE APPEAL-INSTITUTED
- 11 Jan 2023 — EXPARTE APPEAL RECEIVED AT TTAB
- 09 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED